UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN
PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
| Cosmos Health Inc. |
| (Name of Registrant as Specified In Its Charter) |
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
| (1) | Title of each class of securities to which transaction applies: | ||
|
|
| |||
|
|
|
| ||
|
| (2) | Aggregate number of securities to which transaction applies: | ||
|
| ||||
|
|
|
| ||
|
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||
|
| ||||
|
|
|
| ||
|
| (4) | Proposed maximum aggregate value of transaction: | ||
|
| ||||
|
|
|
| ||
|
| (5) | Total fee paid: | ||
|
|
| |||
|
|
| |||
| ☐ | Fee paid previously with preliminary materials. | |||
|
| ||||
|
|
| |||
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11 (a)(2) and identity the filing for which the offsetting fee was paid previously. Identity the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
|
|
|
| ||
|
| (1) | Amount Previously Paid: | ||
|
|
|
| ||
|
|
|
| ||
|
| (2) | Form, Schedule or Registration Statement No.: | ||
|
|
|
| ||
|
|
|
| ||
|
| (3) | Filing Party: | ||
|
|
|
| ||
|
|
|
| ||
|
| (4) | Date Filed: | ||
Cosmos Health Inc.
5 Agiou Georgiou Street
Thessaloniki, Greece 55438
SUPPLEMENT TO PROXY STATEMENT
FOR THE ANNUAL MEETING OF STOCKHOLDERS
To be Held on November 19, 2024
This proxy statement supplement, dated October 29, 2024 (the “Supplement”), supplements the definitive proxy statement (which we refer to as the “Proxy Statement”) of the Board of Directors of Cosmos Health Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission on October 18, 2024 relating to the annual meeting of stockholders of the Company, which will be held on November 19, 2024 at 9:00 A.M. (Central Time) at the Company’s U.S. headquarters, 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604. The purpose of this Supplement is to correct the number of shares of Common Stock of the Company held by Grigorios Siokas. Except as described in this Supplement, the information disclosed in the Proxy Statement continues to apply. To the extent that information in this supplement differs from information disclosed in the proxy statement, the information in this Supplement applies.
Section “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS” of the Definitive Proxy is corrected as follows:
| Name and Address of Beneficial Owners of Common Stock (1) |
| Amount and Nature of Beneficial Ownership |
|
| % of Common Stock |
| ||
|
|
|
|
|
|
|
| ||
| Grigorios Siokas |
|
| 3,516,980 | (2) |
|
| 14.67 | % |
(1) Unless otherwise indicated, the address for each person is 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604.
(2) Includes 2,804,597 issued shares; 212,383 shares issuable upon exercise of Exchange Warrants issued on October 2, 2022, pursuant to a Warrant Exchange Agreement dated as of October 3, 2022; and 500,000 shares issuable upon exercise of Series B Common Warrants exercisable at $3.00 per share. The exercise of the Exchange Warrants, Series B Common Warrants are all subject to the Beneficial Ownership Limitation.
Information about the Company’s 2024 annual meeting of stockholders, scheduled for November 19, 2024, and the director nominees for election are set forth in the Proxy Statement, which is supplemented to reflect the information set forth above. The Proxy Statement, together with this Supplement, have been filed with the Securities and Exchange Commission and are also available for viewing at the website maintained for the annual meeting at https://www.iproxydirect.com/COSM (as well as on the Company’s website at www.cosmoshealthinc.com). The Company will furnish a copy of the Supplement to any stockholder by mail upon written or verbal request to the Company at: Cosmos Health Inc., c/o Corporate Secretary, 141 West Jackson Blvd. Suite 4236, Chicago IL 60604.
Stockholders who have already submitted proxies for this meeting may revoke them, or if they wish to change their vote they may do so by (i) filling out the electronic proxy card at https://www.iproxydirect.com/COSM, (ii) calling the toll-free number for telephone voting that can be found on your proxy card (1-866-752-VOTE(8683), (iii) requesting a new proxy card from the Company at: Issuer Direct Corporation, Attn: James Michael, One Glenwood Avenue, Suite 1001, Raleigh, North Carolina 27603 and mailing the proxy card as instructed in the Proxy Statement, or (iv) by attending the annual meeting in person. To be valid, your vote by Internet, telephone or mail must be received no later than 5:00 p.m. (Central Time) on November 18, 2024. Detailed information regarding voting procedures can be found in the Proxy Statement.
| 2 |